Processa prices $7M public offering of common stock and warrants at $0.25/unit

Processa Pharmaceuticals, Inc.

Gross proceeds of $7M before expenses; offering of 28M shares/pre-funded warrants plus 28M common warrants.
Combined price $0.25 per share (or pre-funded warrant) and accompanying common warrant.
Common warrants exercisable at $0.25/share for 5 years, immediately exercisable.
Net proceeds to fund Phase 2 trial of NGC-Cap and for working capital & general corporate purposes.
H.C. Wainwright acted as placement agent; receives 7% cash fee and 1.12M Placement Agent Warrants.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.